Saturday, February 9, 2008

TriMark Publications Announces TriMark Molecular Diagnostics Conference 2008 in Boston on March 31st

TriMark Publications Announces TriMark Molecular Diagnostics Conference 2008 in Boston on March 31st

TriMark Publications, a global leader in the biotechnology, healthcare and life sciences publishing, announces the TriMark Molecular Diagnostics Conference 2008 entitled: “Personalized Medicine through Genomic Analysis and Molecular Diagnostics.”

New York, NY (PRWEB) November 28, 2007

TriMark Publications (http://www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/)), a global leader in the biotechnology, healthcare and life sciences publishing, announces the TriMark Molecular Diagnostics Conference 2008 entitled:

"Personalized Medicine through Genomic Analysis and Molecular Diagnostics"

The Conference will be held on Monday, March 31, 2008 at Harvard Medical School located at the Joseph B. Martin Conference Center, 77 Avenue Louis Pasteur, Boston, Massachusetts, U. S.A. Registration details at http://www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/).

The TriMark Molecular Diagnostics 2008 Conference has been organized to provide a critical examination of the molecular diagnostics industry, as well as to provide insight from key industry leaders concerning cutting-edge molecular diagnostics technology. This conference will also provide an integral forum for leaders in molecular diagnostics, in vitro diagnostics and laboratories to share ideas, network with other delegates and advance understanding of the potential of new molecular diagnostics technologies. Speakers will include:
 Kaiser Aziz, Ph. D., U. S. Food and Drug Administration (retired)  Joseph Dooley, Ph. D., DABCC, FACB, Chief Executive Officer, TriMark Publications  Helen Fernandes, Ph. D., Department of Pathology and Laboratory Medicine, New Jersey School of Medicine – University Hospital  Harry Glorikian, Managing Partner, Scientia Advisors  Graham Lidgard, Ph. D., Senior VP Research and Development, Nanogen  Gwen McMillian, Ph. D., DABCC, University of Utah, ARUP Laboratory  David Okrongly, Ph. D., Senior VP Molecular Diagnostics, Siemens

Who Should Attend:

 Molecular diagnostics companies.  In vitro diagnostic companies.  Biotechnology companies.  Medical devices manufacturers.  Molecular diagnostic laboratorians

Leaders from the Following Areas Will Greatly Benefit from Attending:

 Laboratory leaders.  Hospital CFOs and CSOs.  Molecular diagnostics and in vitro diagnostic companies.  Business development.  Strategic planning and development.  Technology development.  Marketing.  Research and development.

Key Themes:

 A critical examination of key emerging technologies applicability to molecular diagnostics.  Formation of successful alliances.  Partnering of emerging technologies with molecular diagnostics.  Transitioning from laboratory in vitro diagnostics to molecular diagnostics.

Questions Answered in the TriMark Conference:

 What will the molecular diagnostics market be worth by the end of the decade?  Which market segments will drive molecular diagnostics market growth?  Which new technologies will reach the molecular diagnostics market in the next 2-3 years?  How is technology innovation impacting the dynamics and ownership of the molecular diagnostics industry?  What are the key challenges in gaining acceptance of new technologies by users, payers and regulators?  How is technology innovation facilitating the transition of molecular diagnostics testing into standard healthcare practice?

Top Five Reasons To Attend the TriMark Conference:

 Discover the molecular diagnostics sectors with the greatest prospective growth, ensuring you can successfully align your future strategies with predicted success.  Evaluate the competitive dynamics of the molecular diagnostics market and understand the changing relationship between IVD companies and the molecular diagnostics testing sector.  Identify the key players in the molecular diagnostics market, recognize lucrative partnering opportunities and benchmark your strategies against the leading players.  Assess opportunities and challenges faced by diagnostic companies in gaining acceptance of innovative technologies by payers, regulators and users.  Understand the factors driving growth of the molecular diagnostics market, which represents over 30% of global in vitro diagnostics sales.

Registration Fees for the Conference:

 Early-Bird Registration Fee is $750 until February 29, 2008.  Standard Registration Fee is $995 on and after March 1, 2008.  At-the-Door Fee $1,295 on March 31, 2008 (subject to seating availability).

Register at http://www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/)

About TriMark Publications, LLC

Based in New York City, TriMark Publications is a global leader in biotechnology, healthcare and life sciences publishing. TriMark’s market research reports include the following:

 Animal Health Products Antibacterials Markets  Avian Influenza: The Threatening Pandemic  Bioinformatics Markets  Biomarker Technology Platforms for Cancer Diagnoses and Therapies  Blood Gas Instrumentation Data Processing  Blood Glucose Testing and Diabetes Management  Cancer Diagnostic Testing World Markets  Cancer Therapeutics Markets  Cardiac Marker Diagnostic Testing Markets  Cardiac Rhythm Management Devices World Markets  Cell Therapy Markets  Clinical Chemistry Analyzers  Clinical Immunoanalyzer Markets  Clinical Laboratory Testing Volume 1: Reagents and Instruments  Clinical Laboratory Testing Volume 2: Business Strategies  Cytology and HPV Testing World Markets  Diabetes, Metabolic Syndrome and Cardiovascular Disease  Disposable Medical Supplies Markets  Disposable Syringe Markets  DNA Sequencing and PCR Markets  Drug Discovery Tools for High-Content Analysis  Gene Expression Reagents Markets  Genomics World Markets  Hematology Analyzer Instrumentation and Reagent Markets  High-Growth Diagnostic Tests Markets  Home Healthcare Medical Devices  Indian Pharmaceutical Industry  Key Diagnostic Testing Markets  Mammography World Markets  Medical Imaging Markets  Microarray Markets  Microscopy Markets  Molecular Diagnostics Markets  Multi-Parameter Patient Monitor Markets  Nuclear Cardiology Markets  Nutraceuticals and Dietary Supplements Markets  Over-the-Counter Diagnostic Products Markets  Personalized Medicine  Pharmacogenomic Testing Markets  Point of Care Diagnostic Testing Sector Trends  Point of Care Diagnostic Testing World Markets  Positron Emission Tomography Markets  RNA Interference Markets  Stem Cell Markets  Ultrasound Markets  Veterinary Health Markets  Women\'s Health: Diagnostic Tests

For more information, please visit http://www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/).

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.


TriMark Publications, LLC
Www. trimarkpublications. com/conferences/ (http://www. trimarkpublications. com/conferences/)

# # #